Acorda Therapeutics Human Resources Contracts & Agreements
28 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Compensation Agreements (1)
- Consulting Agreements (3)
- Employment Agreements (16)
- Separation Agreements (1)
- Severance Agreements (1)
- Form of Amendment to Employment Offer Letter, dated March 26, 2024 (Filed With SEC on April 1, 2024)
- Employment letter agreement, dated June 2, 2022, by and between the Registrant and Neil S. Belloff (Filed With SEC on August 9, 2022)
- Employment letter agreement, dated June 2, 2022, by and between the Registrant and Michael Gesser (Filed With SEC on August 9, 2022)
- Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Kerry Clem (Filed With SEC on August 9, 2022)
- Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Lauren Sabella (Filed With SEC on August 9, 2022)
- Employment offer letter, dated November 4, 2021, by and between the Registrant and Neil Belloff (Filed With SEC on March 18, 2022)
- Employment offer letter, dated November 4, 2021, by and between the Registrant and Michael Gesser (Filed With SEC on March 18, 2022)
- Master Consulting Agreement, dated as of January 1, 2022, and Schedule #1 under the Master Consulting Agreement, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
- Separation Agreement and General Release dated December 31, 2021, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
- Amendment dated January 6, 2022, to June 8, 2015 Employment Agreement by and between the Registrant and Lauren Sabella (Filed With SEC on March 18, 2022)
- Employment Agreement dated September 1, 2020, by and between the Company and Kerry Clem (Filed With SEC on September 9, 2021)
- Acorda Therapeutics, Inc. Directors Compensation Policy, as amended April 15, 2021 (Filed With SEC on May 12, 2021)
- Severance policies applicable to Robert Morales, Vice President, Finance and Controller, and interim principal financial and accounting officer (Filed With SEC on May 12, 2021)
- Form of time-based vesting Restricted Stock Unit Agreement for awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan (Filed With SEC on May 12, 2021)
- Consulting Agreement, dated November 11, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on February 28, 2020)
- Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on November 7, 2019)
- Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and David Lawrence (Filed With SEC on November 7, 2019)
- Revised forms of equity award documents for certain awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan (Filed With SEC on August 8, 2017)
- PERFORMANCE UNIT AGREEMENT (Filed With SEC on November 7, 2016)
- FORMS OF EQUITY AWARD DOCUMENTSFOR AWARDS UNDER THE ACORDA THERAPEUTICS, INC. 2015 OMNIBUS INCENTIVE COMPENSATION PLAN (Filed With SEC on August 7, 2015)
- SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- CONSULTING AGREEMENT (Filed With SEC on February 28, 2012)
- ACORDATHERAPEUTICS, INC. 2006EMPLOYEE INCENTIVE PLAN As Amendedas of January 13, 2006 (Filed With SEC on January 18, 2006)
- Employment Agreement (Filed With SEC on January 5, 2006)
- Employment Agreement (Filed With SEC on January 5, 2006)
- Employment Agreement (Filed With SEC on January 5, 2006)
- ACORDA THERAPEUTICS, INC. 2006 EMPLOYEE INCENTIVE PLAN (Filed With SEC on January 5, 2006)
